ClinicalTrials.govpublic full text
Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and as a Urinary Biomarker
overactive bladder syndrome, detrusor overactivity, mirabegron, beta3-adrenoceptor agonist, urodynamics, biomarker, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 845455
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.